Cargando…

Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID‐19: A Retrospective Multicenter Study in the United States

Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories for clinical use. We sought to characterize the pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevenson, James M., Alexander, G. Caleb, Palamuttam, Natasha, Mehta, Hemalkumar B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877860/ https://www.ncbi.nlm.nih.gov/pubmed/33085221 http://dx.doi.org/10.1111/cts.12919

Ejemplares similares

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016
por: Ardeshirrouhanifard, Shirin, et al.
Publicado: (2022)

A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China
por: Huang, Quanfei, et al.
Publicado: (2023)

Race, Ethnicity, and Pharmacogenomic Variation in the United States and the United Kingdom
por: Sharma, Shivam, et al.
Publicado: (2023)

Population structure and pharmacogenomic risk stratification in the United States
por: Nagar, Shashwat Deepali, et al.
Publicado: (2020)

1316. Clinical Utility of Pharmacogenomic Testing in Refractory Coccidioidal Meningitis
por: Blair, Janis E, et al.
Publicado: (2023)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
por: Kisor, David F, et al.
Publicado: (2021)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
por: Zhang, Lusi, et al.
Publicado: (2022)

Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
por: Winner, Joel G., et al.
Publicado: (2015)

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals
por: Wang, Yang, et al.
Publicado: (2021)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study
por: Tagwerker, Christian, et al.
Publicado: (2022)

Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin
por: Boothman, Isabelle, et al.
Publicado: (2023)

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
por: Pearce, Angela, et al.
Publicado: (2022)

Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008)

Individualization of antiretroviral therapy - Pharmacogenomic aspect
por: Dalal, Bhavik, et al.
Publicado: (2015)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
por: Van Heukelom, Joel, et al.
Publicado: (2023)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

Clinical utility of pharmacogenomics in the management of hepatitis C
por: Trinks, Julieta, et al.
Publicado: (2014)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Projecting hospital utilization during the COVID-19 outbreaks in the United States
por: Moghadas, Seyed M., et al.
Publicado: (2020)

Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
por: Hetti Arachchilage, Madara
Publicado: (2022)

Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”
por: Rathi, Komal
Publicado: (2022)

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
por: Mehta, Hemalkumar B, et al.
Publicado: (2020)

Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan
por: Shimazawa, R, et al.
Publicado: (2014)

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
por: Samwald, Matthias, et al.
Publicado: (2016)

Psychiatric pharmacogenomic testing in clinical practice
por: Mrazek, David A.
Publicado: (2010)

Overview of pharmacogenomic testing in clinical practice
por: Gross, Tonya, et al.
Publicado: (2018)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Loh, Feng-Hua, et al.
Publicado: (2021)

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information
por: Stanek, Eric J., et al.
Publicado: (2013)

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020)

Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program
por: Melendez, Karina, et al.
Publicado: (2023)

Association between unemployment rates and prescription drug utilization in the United States, 2007–2010
por: Kozman, Daniel, et al.
Publicado: (2012)

A pharmacogenomic method for individualized prediction of drug sensitivity
por: Cohen, Adam L, et al.
Publicado: (2011)

Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States
por: Sun, Boguang, et al.
Publicado: (2023)

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
por: Zhou, Shuqin, et al.
Publicado: (2018)

Demand for Pharmacogenomics and Personalized Medicine in the United Arab Emirates
por: Jarrar, Yazun, et al.
Publicado: (2022)

The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
por: Benitez, Joachim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pcpgs8gtlm1b5en622pane26j9